Drug Trial Radar · NCT06780306
A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.
Last checked: Nov 19, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Dec 12, 2024
Primary completion
Jan 30, 2026
Study completion Jan 30, 2026
Sponsor
- Lead sponsor
- BioTissue Holdings, IncIndustry
- Sponsor type
- Industry
- First posted
- Jan 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED. The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness. Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness. Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.
Conditions
- Dry Eye
- Dry Eye Disease (DED)
- Dry Eye Disease With Severe Keratitis
Interventions
TTAX03Biological
Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord
Saline (NaCl 0,9 %) (placebo)Biological
300 mL Sterile, preservative free 0.9% NaCl
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determine 12 week ocular and general safety after application of TTAX03.Time frame: 12 weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
University California Berkeley
Berkeley, California
Advanced Research, LLC.
Deerfield Beach, Florida
Southwest Eye Care
Chaska, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
Eye Associates of North Jersey
Dover, New Jersey
Northern New Jersey Eye Institute
South Orange, New Jersey
Wilmington Eye at Brunswick Forest
Leland, North Carolina
CORE, Inc. / Vita Eye Clinic
Shelby, North Carolina
Westlake Eye Specialists
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.